作者
Tian‐Liang Xia, Xingyang Li, Xueping Wang, Yun‐Jia Zhu, Hua Zhang, Weisheng Cheng, Mei‐Ling Chen, Ying Ye, Yan Li, Ao Zhang, Dan‐Ling Dai, Qian‐Ying Zhu, Li Yuan, Jian Zheng, Huilin Huang, Si‐Qi Chen, Zhi‐Wen Xiao, Hong‐Bo Wang, Gaurab Roy, Qian Zhong, Dongxin Lin, Yi‐Xin Zeng, Jinkai Wang, Bo Zhao, Benjamin E Gewurz, Jianjun Chen, Zhixiang Zuo, Mu‐Sheng Zeng
发表日期
2021/4/7
期刊
EMBO reports
卷号
22
期号
4
页码范围
e50128
简介
N6‐methyladenosine (m6A) modification of mRNA mediates diverse cellular and viral functions. Infection with Epstein–Barr virus (EBV) is causally associated with nasopharyngeal carcinoma (NPC), 10% of gastric carcinoma, and various B‐cell lymphomas, in which the viral latent and lytic phases both play vital roles. Here, we show that EBV transcripts exhibit differential m6A modification in human NPC biopsies, patient‐derived xenograft tissues, and cells at different EBV infection stages. m6A‐modified EBV transcripts are recognized and destabilized by the YTHDF1 protein, which leads to the m6A‐dependent suppression of EBV infection and replication. Mechanistically, YTHDF1 hastens viral RNA decapping and mediates RNA decay by recruiting RNA degradation complexes, including ZAP, DDX17, and DCP2, thereby post‐transcriptionally downregulating the expression of EBV genes. Taken together, our …
引用总数
20202021202220232024110272114